Kindred Bio Announces Closing of Initial Public Offering and Exercise of Over-Allotment Option

SAN FRANCISCO, April 8, 2014 /PRNewswire/ — Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and …